Research Articles | Page 13 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Patient preferences and quality of life implications of ravulizumab (every 8 weeks) and eculizumab (every 2 weeks) for the treatment of paroxysmal nocturnal hemoglobinuria. Sep 2020 PloS One Paroxysmal Nocturnal Hemoglobinuria (PNH)
Patient and physician perceptions about blood transfusions in the myelodysplastic syndromes Jul 2020 Leukemia Research Myelodysplastic Syndromes (MDS)
Parsing the Paradox of Myelodysplastic Syndromes Dec 2020 Journal of clinical oncology: official journal of the American Society Clinical Oncologysd Myelodysplastic Syndromes (MDS)
Paroxysmal nocturnal hemoglobinuria: Where we stand May 2023 American Journal of Hematology Paroxysmal Nocturnal Hemoglobinuria (PNH)
Paroxysmal nocturnal hemoglobinuria: Where are we going May 2023 American Journal of Hematology Paroxysmal Nocturnal Hemoglobinuria (PNH)
Paroxysmal nocturnal hemoglobinuria: role of the complement system, pathogenesis, and pathophysiology Dec 2020 Journal of Managed care and specialty pharmacy Paroxysmal Nocturnal Hemoglobinuria (PNH)
Paroxysmal nocturnal hemoglobinuria: Review of the patient experience and treatment landscape Mar 2024 Blood Reviews Paroxysmal Nocturnal Hemoglobinuria (PNH)
Paroxysmal nocturnal hemoglobinuria: patient journey and burden of disease Dec 2020 Journal of Managed care and specialty pharmacy Paroxysmal Nocturnal Hemoglobinuria (PNH)
Paroxysmal nocturnal hemoglobinuria: current treatments and unmet needs Dec 2020 Journal of Managed care and specialty pharmacy Paroxysmal Nocturnal Hemoglobinuria (PNH)
Paroxysmal Nocturnal Hemoglobinuria: Current Management, Unmet Needs, and Recommendations Dec 2023 Journal of Blood Medicine Paroxysmal Nocturnal Hemoglobinuria (PNH)